Skip to main content
ISU Abxis Co., Ltd. logo

ISU Abxis Co., Ltd. — Investor Relations & Filings

Ticker · 086890 ISIN · KR7086890001 KO Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 086890

About ISU Abxis Co., Ltd.

https://www.abxis.com/eng/index.do

ISU Abxis is a biopharmaceutical company specializing in the research and development of innovative biomedicines, primarily engineered antibody-based immunotherapies. Founded in 2001, the company leverages genetic recombination technology to create novel treatments. Its pipeline is focused on addressing significant unmet medical needs in oncology and rare diseases. Key development programs include therapeutics for cancers like Head and Neck Squamous Cell Carcinoma (ISU104) and treatments for rare genetic disorders such as Fabry disease (Fabagal). The company is dedicated to developing advanced antibody-based therapeutics to improve the quality of life for patients with difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
소속부변경
Regulatory Filings
2026-04-30 Korean
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is a public notice in Korean titled ‘기업설명회(IR) 개최’, detailing the date, time, venue, audience, purpose, and agenda of an investor relations presentation day. It is not a financial report, earnings release, or management change notice, but an announcement of an upcoming investor presentation event. Under the taxonomy, this best matches an Investor Presentation (IP).
2026-03-30 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 1% confidence The document is a regulatory announcement detailing the company’s acquisition of its own convertible bonds (pre-maturity repurchase), including bond terms, amounts, dates, and reasons. This is not an earnings or annual report nor a board change, but a financing transaction affecting capital structure. Such debt repurchases fall under Capital/Financing Update.
2026-03-23 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend resolutions, director/auditor appointments, and voting outcomes for specific agenda items. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from ISU ABXIS. It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, etc.), and auditor information. While it contains financial data, it is a short, standardized regulatory announcement notifying the market that the audit report has been submitted, rather than the full audit report document itself. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). FY 2025
2026-03-12 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the 25th fiscal year (2025) of ISU Abxis Co., Ltd. It contains comprehensive financial statements, management discussion and analysis, business overview, and governance information, which are the defining characteristics of an Annual Report (10-K). FY 2025
2026-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.